These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG, Dellweg H, Perzborn E, Gross R. Biochem Pharmacol; 1992 Aug 04; 44(3):495-503. PubMed ID: 1387312 [Abstract] [Full Text] [Related]
25. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets. Dorn GW. J Clin Invest; 1989 Dec 04; 84(6):1883-91. PubMed ID: 2531760 [Abstract] [Full Text] [Related]
26. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets. Turini ME, Holub BJ. Biochim Biophys Acta; 1994 Jun 23; 1213(1):21-6. PubMed ID: 8011675 [Abstract] [Full Text] [Related]
27. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC. Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474 [Abstract] [Full Text] [Related]
29. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist. Hanasaki K, Arita H. Biochim Biophys Acta; 1989 Sep 04; 1013(1):28-35. PubMed ID: 2528990 [Abstract] [Full Text] [Related]